- Home
- VTVT vs ZYXI Comparison
VTVT vs ZYXI Comparison
Compare VTVT & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTVT
- ZYXI
- Stock Information
- Founded
- VTVT 2015
- ZYXI 1996
- Country
- VTVT United States
- ZYXI United States
- Employees
- VTVT N/A
- ZYXI N/A
- Industry
- VTVT Biotechnology: Pharmaceutical Preparations
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VTVT Health Care
- ZYXI Health Care
- Exchange
- VTVT Nasdaq
- ZYXI Nasdaq
- Market Cap
- VTVT 47.9M
- ZYXI 44.8M
- IPO Year
- VTVT 2015
- ZYXI N/A
- Fundamental
- Price
- VTVT $21.03
- ZYXI $1.50
- Analyst Decision
- VTVT Strong Buy
- ZYXI Hold
- Analyst Count
- VTVT 2
- ZYXI 3
- Target Price
- VTVT $35.50
- ZYXI $3.00
- AVG Volume (30 Days)
- VTVT 3.4K
- ZYXI 103.1K
- Earning Date
- VTVT 11-11-2025
- ZYXI 10-23-2025
- Dividend Yield
- VTVT N/A
- ZYXI N/A
- EPS Growth
- VTVT N/A
- ZYXI N/A
- EPS
- VTVT N/A
- ZYXI N/A
- Revenue
- VTVT $17,000.00
- ZYXI $144,808,000.00
- Revenue This Year
- VTVT N/A
- ZYXI N/A
- Revenue Next Year
- VTVT N/A
- ZYXI $7.07
- P/E Ratio
- VTVT N/A
- ZYXI N/A
- Revenue Growth
- VTVT N/A
- ZYXI N/A
- 52 Week Low
- VTVT $12.62
- ZYXI $1.23
- 52 Week High
- VTVT $26.99
- ZYXI $9.42
- Technical
- Relative Strength Index (RSI)
- VTVT 75.87
- ZYXI 42.77
- Support Level
- VTVT $19.15
- ZYXI $1.44
- Resistance Level
- VTVT $21.40
- ZYXI $1.55
- Average True Range (ATR)
- VTVT 1.20
- ZYXI 0.09
- MACD
- VTVT 0.32
- ZYXI 0.02
- Stochastic Oscillator
- VTVT 92.81
- ZYXI 29.03
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.